James Spicer is a Reader in the Cancer Studies Division of King’s College London, and Honorary Consultant in Medical Oncology at Guy’s and St. Thomas’ Hospitals. He trained at major London teaching hospitals, has a Ph.D. in cancer biology from the Institute of Cancer Research in London, and a degree in biochemistry from the University of Oxford. Dr Spicer specialises in the treatment of thoracic malignancies especially lung cancer. His research interests include early phase trials, and novel therapies for lung cancer and other thoracic malignancies. He has established a phase I programme in solid tumour oncology at Guy’s Hospital, and is lead for thoracic medical oncology. He co-leads the King’s Experimental Cancer Medicine Centre, and a member of the Board of the King’s Health Partners Clinical Trials Office. He also conducts translational research on novel immunotherapies, pharmacogenetics and molecular diagnostics. He is a member of the British Thoracic Oncology Group steering committee, and sits on CRUK’s New Agents committee and other national research funding panels. He is the author of more than 70 peer-reviewed publications.

 cancer, oncology, cancer biology, tumour